Response to 'Comment on: "Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases"'

Ivan Seah; Xin Xin Zhao; Qianyu Lin; Zengping Liu; Steven Zheng Zhe Su; Yew Sen Yuen; Walter Hunziker; Gopal Lingam; Xian Jun Loh; Xinyi Su

doi:10.1038/s41433-020-0983-0

Response to 'Comment on: "Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases"'

Eye (Lond). 2021 Mar;35(3):1026-1027. doi: 10.1038/s41433-020-0983-0. Epub 2020 May 28.

Authors

Ivan Seah¹, Xin Xin Zhao², Qianyu Lin³, Zengping Liu⁴, Steven Zheng Zhe Su⁵, Yew Sen Yuen¹, Walter Hunziker^{2

6}, Gopal Lingam^{7

8}, Xian Jun Loh⁹, Xinyi Su^{10

11

12

13}

Affiliations

¹ Department of Ophthalmology, National University Hospital Singapore, Singapore, Singapore.
² Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
³ Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
⁴ Department of Ophthalmology, Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore.
⁵ Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
⁶ Department of Physiology, National University of Singapore, Singapore, Singapore.
⁷ Department of Ophthalmology, National University Hospital Singapore, Singapore, Singapore. gopal_lingam@nuhs.edu.sg.
⁸ Department of Ophthalmology, Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore. gopal_lingam@nuhs.edu.sg.
⁹ Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. lohxj@imre.a-star.edu.sg.
¹⁰ Department of Ophthalmology, National University Hospital Singapore, Singapore, Singapore. xinyi_su@nuhs.edu.sg.
¹¹ Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. xinyi_su@nuhs.edu.sg.
¹² Department of Ophthalmology, Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore. xinyi_su@nuhs.edu.sg.
¹³ Department of Physiology, National University of Singapore, Singapore, Singapore. xinyi_su@nuhs.edu.sg.

No abstract available

Publication types

Letter
Comment

MeSH terms

Bevacizumab
Biocompatible Materials*
Humans
Retinal Diseases*

Substances

Biocompatible Materials
Bevacizumab